PIP
LLY icon

Peachtree Investment Partners’s Eli Lilly LLY Stock Holding History

Peachtree Investment Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$20M Sell
21,778
-909
-4% -$922K 7.63% 3
2025
Q4 		$24.4M Sell
22,687
-135
-0.6% -$129K 8.09% 3
2025
Q3 		$17.4M Sell
22,822
-1,306
-5% -$972K 6.04% 4
2025
Q2 		$18.8M Sell
24,128
-808
-3% -$628K 7.18% 3
2025
Q1 		$20.6M Sell
24,936
-691
-3% -$575K 8.14% 3
2024
Q4 		$19.8M Sell
25,627
-1,984
-7% -$1.64M 7.41% 3
2024
Q3 		$24.5M Sell
27,611
-197
-0.7% -$177K 9.2% 3
2024
Q2 		$25.2M Buy
27,808
+43
+0.2% +$34.4K 9.88% 3
2024
Q1 		$21.6M Sell
27,765
-2,720
-9% -$1.94M 8.73% 3
2023
Q4 		$17.8M Sell
30,485
-898
-3% -$524K 7.29% 3
2023
Q3 		$16.9M Buy
31,383
+6,169
+24% +$3.18M 8.6% 3
2023
Q2 		$11.8M Buy
25,214
+14,298
+131% +$6M 5.4% 4
2023
Q1 		$3.75M Sell
10,916
-6,887
-39% -$2.32M 2.34% 12
2022
Q4 		$6.51M Buy
17,803
+3,883
+28% +$1.38M 3.98% 5
2022
Q3 		$4.5M Buy
13,920
+1,013
+8% +$321K 3.02% 8
2022
Q2 		$4.18M Buy
12,907
+6,608
+105% +$1.98M 2.61% 8
2022
Q1 		$1.8M Sell
6,299
-202
-3% -$52K 0.83% 26
2021
Q4 		$1.8M Buy
6,501
+1,304
+25% +$331K 0.75% 28
2021
Q3 		$1.2M Buy
5,197
+350
+7% +$86.4K 0.59% 32
2021
Q2 		$1.11M Sell
4,847
-219
-4% -$44K 0.54% 33
2021
Q1 		$946K Buy
5,066
+437
+9% +$85.5K 0.54% 34
2020
Q4 		$782K Buy
4,629
+30
+0.7% +$4.48K 0.46% 35
2020
Q3 		$681K Buy
+4,599
New +$712K 0.47% 36
2020
Q2 		– Sell
-4,510
Closed -$625K – 76
2020
Q1 		$625K Sell
4,510
-293
-6% -$40.3K 0.63% 26
2019
Q4 		$631K Sell
4,803
-1,589
-25% -$184K 0.44% 38
2019
Q3 		$715K Sell
6,392
-2,200
-26% -$245K 0.57% 35
2019
Q2 		$952K Sell
8,592
-13,401
-61% -$1.58M 0.75% 27
2019
Q1 		$2.85M Buy
21,993
+11,026
+101% +$1.34M 2.41% 15
2018
Q4 		$1.27M Buy
+10,967
New +$1.23M 1.44% 19

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Peachtree Investment Partners's LLY Position: Q1 2026 in Review

Peachtree Investment Partners reduced its Eli Lilly (LLY) stake by 4% in Q1 2026, selling an estimated $922K and leaving 21,778 shares worth $20M. The position accounts for 7.63% of the portfolio, ranked #3.

Peachtree Investment Partners first reported a position in LLY in Q4 2018 and has held it in 29 quarters since. The position peaked at $25.2M in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Peachtree Investment Partners held 21,778 shares of Eli Lilly worth $20M as of Q1 2026.
  • Peachtree Investment Partners sold 909 Eli Lilly shares in Q1 2026, an estimated $922K.
  • Eli Lilly made up 7.63% of Peachtree Investment Partners's portfolio in Q1 2026, its #3 holding.
  • Peachtree Investment Partners first reported a position in Eli Lilly in Q4 2018 and has held it in 29 quarters since.
  • Peachtree Investment Partners's Eli Lilly position peaked at $25.2M in Q2 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Peachtree Investment Partners's 13F filing for Q1 2026, filed 8 May 2026.